Adverse Effects of Retinoids

@article{David1988AdverseEO,
  title={Adverse Effects of Retinoids},
  author={Michael David and Emmilia Hodak and Nick J Lowe},
  journal={Medical Toxicology and Adverse Drug Experience},
  year={1988},
  volume={3},
  pages={273-288}
}
SummaryOral retinoids, synthetic derivatives of vitamin A, have been used in the treatment of various dermatoses over the last decade. The most useful drugs have been isotretinoin (13- cisretinoic acid) for nodulocystic acne and etretinate for psoriasis vulgaris. Retinoids are also effective in the treatment of papulosquamous dermatoses other than psoriasis (i.e. inherited disorders of keratinisation), cutaneous T-cell lymphoma and in chemotherapy and chemoprevention of cancer. However… Expand
A new generation of retinoid drugs for the treatment of dermatological diseases
TLDR
There is considerable interest in developing novel retinoids that exhibit improvements in the side-effect profile, particularly for diseases that require chronic administration. Expand
Section Review: Retinoids: Biological Function and Use in the Treatment of Dermatological Diseases: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis
TLDR
A new generation of retinoids and retinoid treatments which are in clinical development and which exhibi... Expand
Neuromuscular Adverse Effects Associated with Systemic Retinoid Dermatotherapy
TLDR
Systemic diseases with involvement of nervous and/or muscle tissue and neuromuscular disorders should be regarded as exclusion criteria for initiation of oral retinoid therapy and intense physical exercise and concurrent treatment with neurotoxic or myotoxic drugs should be avoided during treatment with Oral retinoids. Expand
Adverse Reactions to Oral Retinoids
SummaryRetinoids, both naturally occurring and synthetic, are analogues of vitamin A. They represent a major advance in the treatment of acne and psoriasis, as well as rarer conditions such as theExpand
Cutaneous Reactions to Retinoids
Since their introduction in the 1980s, retinoids have been increasingly used for both the topical and systemic treatment of many disorders including, but not limited, to hyper- and parakeratoticExpand
A review of acitretin, a systemic retinoid for the treatment of psoriasis
TLDR
Acitretin is a second-generation, systemic retinoid that has been approved for the treatment of psoriasis since 1997 and is generally safe for long-term use and has no time limit restrictions, which makes it useful in combination therapy and for maintenance therapy. Expand
Systemic retinoids in chemoprevention of non-melanoma skin cancer
TLDR
The pharmacokinetics and dose regimens of the two most commonly used oral retinoids (isotretinoin and acitretin) in the chemoprevention of non-melanoma skin cancers are presented and are associated with adverse effects, which are discussed in detail. Expand
Retinoids Delivery Systems in Cancer: Liposomal Fenretinide for Neuroectodermal-Derived Tumors
TLDR
The use and the therapeutic results obtained by using fenretinide-loaded liposomes against neuroectodermal-derived tumors, such as melanoma, in adults, and neuroblastoma, the most common extra-cranial solid tumor of childhood, will be discussed. Expand
Comparative Tolerability of Systemic Treatments for Plaque-Type Psoriasis
TLDR
The potential adverse effects with these US Food and Drug Administration-approved treatments in adults are examined, with specific emphasis on the controversies that surround long-term therapy with these agents and their cumulative adverse effects. Expand
The use of retinoids in the pediatric patient.
TLDR
Oral retinoids are molecules derived from vitamin A that represent one of the most important steps forward in dermatologic therapeutics in the present century and specialists should be prepared to maneuver the delicate balance between therapeutic efficacy and side effects. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 131 REFERENCES
The development of retinoids in experimental and clinical oncology and dermatology.
  • W. Bollag
  • Medicine
  • Journal of the American Academy of Dermatology
  • 1983
TLDR
Three particular compounds have achieved remarkable usefulness in dermatology: 13-cis-retinoic acid in the treatment of cystic acne, the aromatic retinoid etretinate in the therapy of severe forms of psoriasis, and an arotinoid. Expand
Visual and cutaneous toxicity which occurs during N‐(4‐hydroxyphenyl) retinamide therapy for psoriasis
TLDR
The experience of unusual side‐effects which occur during a phase II clinical trial of (N‐[4‐Hydroxyphenyl] retinamide)(4HPR) in the treatment of severe chronic plaque psoriasis is reported. Expand
Oral synthetic retinoid treatment in children.
TLDR
In this report 15 patients with chronic disorders of keratinization and one patient with severe cystic acne were treated with oral isotretinoin and the degree of clinical response and duration of post-treatment remission varied with the different disorders. Expand
Toxic effects of the aromatic retinoid etretinate.
TLDR
The aromatic retinoid etretinate was administered to a series of 59 patients, 34 of which had psoriasis and 25 of whom had nonpsoriatic disease, finding no abnormalities in the peripheral blood cell counts or blood glucose, serum creatinine, serum nonprotein, and nitrogen levels. Expand
Oral isotretinoin (13-cis-retinoic acid) therapy in severe acne: drug and vitamin A concentrations in serum and skin.
TLDR
The results suggest that isotretinoin therapy interferes with the endogenous vitamin A metabolism in the skin. Expand
Retinoids: a review.
  • C. Dicken
  • Medicine
  • Journal of the American Academy of Dermatology
  • 1984
TLDR
Basic knowledge of retinoids is reviewed, the current status of studies are reviewed, and the present and future roles of these drugs in dermatology are speculated on. Expand
Ophthalmological effects of 13‐cis‐retinoic acid therapy for acne vulgaris
TLDR
The lack of gross changes in the presence of a 70% reduction in sebum excretion rate suggests that the drug is not grossly affecting tear secretion or its lipid component, and this infection is not a secondary effect due to a marked reduction in tear secretion. Expand
Pharmacology of 13-cis-retinoic acid in humans.
TLDR
Although there was a linear correlation of plasma concentration with dose escalation, large inter-individual variations in peak plasma concentrations were noted, and the drug was metabolized extensively to a metabolite, the concentrations of which exceeding parent 13-cis-retinoic acid concentrations with chronic dosing. Expand
Long-Term Effects of Etretinate on the Liver in Psoriasis
TLDR
There is a need for periodic liver biopsy to monitor patients on long-term etretinate therapy, as the results of this study suggest. Expand
Etretinate and Isotretinoin, Two Retinoids with Different Pharmacokinetic Profiles
The development of vitamin A analogue compounds for use as therapeutic agents was mainly governed by the challenge to dissociate pharmacological effects from toxic side-effects, known as theExpand
...
1
2
3
4
5
...